These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9855502)

  • 61. Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression.
    Bradley MA; Xiong-Fister S; Markesbery WR; Lovell MA
    Neurobiol Aging; 2012 Jun; 33(6):1034-44. PubMed ID: 20965613
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid.
    Lovell MA; Markesbery WR
    Arch Neurol; 2001 Mar; 58(3):392-6. PubMed ID: 11255442
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reduction of brain lipid peroxidation by CSF drainage in Alzheimer's disease patients.
    Praticò D; Yao Y; Rokach J; Mayo M; Silverberg GG; McGuire D
    J Alzheimers Dis; 2004 Aug; 6(4):385-9; discussion 443-9. PubMed ID: 15345808
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Elevated CSF prostaglandin E2 levels in patients with probable AD.
    Montine TJ; Sidell KR; Crews BC; Markesbery WR; Marnett LJ; Roberts LJ; Morrow JD
    Neurology; 1999 Oct; 53(7):1495-8. PubMed ID: 10534257
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects.
    Fisher G; Lorenzo N; Abe H; Fujita E; Frey WH; Emory C; Di Fiore MM; D' Aniello A
    Amino Acids; 1998; 15(3):263-9. PubMed ID: 9871505
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Free D-amino acids in human cerebrospinal fluid of Alzheimer disease, multiple sclerosis, and healthy control subjects.
    Fisher GH; Petrucelli L; Gardner C; Emory C; Frey WH; Amaducci L; Sorbi S; Sorrentino G; Borghi M; D'Aniello A
    Mol Chem Neuropathol; 1994; 23(2-3):115-24. PubMed ID: 7702702
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Brain cytochrome oxidase in Alzheimer's disease.
    Kish SJ; Bergeron C; Rajput A; Dozic S; Mastrogiacomo F; Chang LJ; Wilson JM; DiStefano LM; Nobrega JN
    J Neurochem; 1992 Aug; 59(2):776-9. PubMed ID: 1321237
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis.
    Di Domenico F; Cenini G; Sultana R; Perluigi M; Uberti D; Memo M; Butterfield DA
    Neurochem Res; 2009 Apr; 34(4):727-33. PubMed ID: 19199029
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease.
    Bradley MA; Markesbery WR; Lovell MA
    Free Radic Biol Med; 2010 Jun; 48(12):1570-6. PubMed ID: 20171275
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Orchestration of Genetic Alterations in
    Mir A; Kamran Z; Iqbal W
    Glob Med Genet; 2024 Jan; 11(1):1-12. PubMed ID: 38213663
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of the relationship among gene expressions and enzyme activities with antioxidant role and presenilin 1 expression in Alzheimer's disease.
    Işık M; Tunç A; Duran HE; Naldan ME; Yılmaz A; Koçak MN; Beydemir Ş
    J Cell Mol Med; 2023 Nov; 27(21):3388-3394. PubMed ID: 37772794
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Implication of the cooking oil-peroxidation product "hydroxynonenal" for Alzheimer's disease.
    Yamashima T; Seike T; Mochly-Rosen D; Chen CH; Kikuchi M; Mizukoshi E
    Front Aging Neurosci; 2023; 15():1211141. PubMed ID: 37693644
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Role of Acrolein in Neurodegenerative Diseases and Its Protective Strategy.
    Chang X; Wang Y; Zheng B; Chen Y; Xie J; Song Y; Ding X; Hu X; Hu X; Yu Q
    Foods; 2022 Oct; 11(20):. PubMed ID: 37430952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxidative Stress: Glutathione and Its Potential to Protect Methionine-35 of Aβ Peptide from Oxidation.
    Mandal PK; Roy RG; Samkaria A
    ACS Omega; 2022 Aug; 7(31):27052-27061. PubMed ID: 35967059
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pesticides Exposure-Induced Changes in Brain Metabolome: Implications in the Pathogenesis of Neurodegenerative Disorders.
    Rodrigues JA; Narasimhamurthy RK; Joshi MB; Dsouza HS; Mumbrekar KD
    Neurotox Res; 2022 Oct; 40(5):1539-1552. PubMed ID: 35781222
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Generation of Human iPSC-Derived Astrocytes with a mature star-shaped phenotype for CNS modeling.
    Voulgaris D; Nikolakopoulou P; Herland A
    Stem Cell Rev Rep; 2022 Oct; 18(7):2494-2512. PubMed ID: 35488987
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases.
    Hyun DH; Lee J
    Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052511
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ferroptosis, a Potential Therapeutic Target in Alzheimer's Disease.
    Chen K; Jiang X; Wu M; Cao X; Bao W; Zhu LQ
    Front Cell Dev Biol; 2021; 9():704298. PubMed ID: 34422824
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease.
    Behl T; Kaur I; Sehgal A; Kumar A; Uddin MS; Bungau S
    Mol Neurobiol; 2021 Apr; 58(4):1564-1582. PubMed ID: 33215389
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic variants beyond amyloid and tau associated with cognitive decline: A cohort study.
    Kim HR; Lee T; Choi JK; Jeong Y;
    Neurology; 2020 Oct; 95(17):e2366-e2377. PubMed ID: 32938779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.